ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.26
+4.16%Margins
Gross margin
96.4%
EBITDA margin
1.2%
EBIT margin
-4.5%
Net margin
2.9%
FCF margin
-65.9%
1.7%
Return on equity
1.4%
Return on assets
-2.5%
Return on invested capital
0.48x
Asset turnover
-$207.0M
Cash from operations
$8.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026